Risks and benefits of phase 1 oncology trials, revisited.
Kurzrock
Razelle
R
Benjamin
Robert S
RS
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D017321:Clinical Trials, Phase I as Topic / Q000941:ethics; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D018570:Risk Assessment
D000970:Antineoplastic Agents